These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2474776)

  • 21. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.
    Hutson PH; Dourish CT; Curzon G
    Eur J Pharmacol; 1986 Oct; 129(3):347-52. PubMed ID: 2430815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.
    Bonvento G; Scatton B; Claustre Y; Rouquier L
    Neurosci Lett; 1992 Mar; 137(1):101-4. PubMed ID: 1385646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin.
    Bosker F; Klompmakers A; Westenberg H
    J Neurochem; 1994 Dec; 63(6):2165-71. PubMed ID: 7964736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997.
    Hirose A; Sasa M; Akaike A; Takaori S
    Neuropharmacology; 1990 Feb; 29(2):93-101. PubMed ID: 1970426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased population spike amplitude in the dentate gyrus following systemic administration of 5-hydroxytryptophan or 8-hydroxy-2-(di-n-propylamino)tetralin.
    Klancnik JM; Baimbridge KG; Phillips AG
    Brain Res; 1989 Dec; 505(1):145-8. PubMed ID: 2532947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of route of administration on potency of the selective 5HT-1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):409-12. PubMed ID: 2449711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of hippocampal serotonin release and locomotor activity following pharmacological manipulations of the median raphe nucleus.
    Shim I; Javaid J; Wirtshafter D
    Behav Brain Res; 1997 Dec; 89(1-2):191-8. PubMed ID: 9475626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of 5-hydroxytryptamine (5-HT) from medullary and mesencephalic raphé neurones after grafting to the rat hippocampus: evidence for regulation by 5-HT1A autoreceptors.
    Sharp T; Foster GA
    Neurosci Lett; 1991 Nov; 132(2):179-82. PubMed ID: 1838408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.
    Bendotti C; Samanin R
    Eur J Pharmacol; 1986 Feb; 121(1):147-50. PubMed ID: 2937644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei.
    Kreiss DS; Lucki I
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1268-79. PubMed ID: 8014870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 8-hydroxy-2-(di-n-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain.
    Fernstrom MH; Massoudi MS; Fernstrom JD
    Life Sci; 1990; 47(4):283-9. PubMed ID: 2143798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe.
    Fletcher PJ
    Brain Res; 1991 Jun; 552(2):181-9. PubMed ID: 1833034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment.
    Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Gadek-Michalska A; Wedzony K
    Neuropsychopharmacology; 2003 Jul; 28(7):1300-10. PubMed ID: 12700680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.